The Government of India has started a new health scheme called AMRIT (Affordable Medicines and Reliable Implants for Treatment) Retail Pharmacy. The cancer medicine will be sold at discounted and subsidized rates. The first pilot project has been launched at AIIMS, Delhi, and it will be run by HLL Lifecare.

The medical treatment are inadequate and expenses to meet the demand for masses. Every year 700,000 people are diagnosed with cancer and required low cost and budgeted treatment and medicines. Hence, one of the schemes is started by the government where retail medicine shop is opened to help out the patients who can not afford expensive cardiovascular drugs and cancer medicines.

To begin with, HLL has dispensed 195 oncology(study of cancer cell) drugs, 186 cardiovascular drugs and 148 cardiac implants through AMRIT pharmacy. Initially, cancer drugs will be available at more than half of the reduced rates than available in open market and after sometimes, the cardiovascular drugs will be available too.

 Under the scheme, drugs will be sold at a fraction of the market price. Docetaxel 120mg, used for chemotherapy cycle, will be priced at Rs 888.75 (93 per cent rebate for one cycle), while the MRP of the injection is Rs 13,440. Similarly, Carboplatin 450 mg would be sold at Rs 1,316.25 while its MRP is Rs 2,561.57.

Based on the outcome of the AIIMS outlet, this initiative will be taken to other central government hospitals and Regional Cancer Centres, announced by JP Nadda, Union Health minister.

Get Free Email Updates!

Signup now and receive an email once I publish new content.

I agree to have my personal information transfered to MailChimp ( more information )

I will never give away, trade or sell your email address. You can unsubscribe at any time.